Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000947

Drug Information
NameSalmeterol
SynonymsGlaxo Wellcome brand of salmeterol xinafoate; MLS000759000; TL80090037; MLS001424322; BRD-A01320529-001-05-9; 1,3-Benzenedimethanol, 4-hydroxy-alpha(sup 1)-(((6-(4-phenylbutoxy)hexyl)amino)methyl-, (+-)-; Serevent; HSDB 7315; C07241; Prestwick3_000945; 94749-08-3 (xinafoate); CPD000466295; SMR000466295; AB00513972; Salmeterolum; 1,3-Benzenedimethanol, 4-hydroxy-alpha(sup 1)-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-, (+-)-; BPBio1_001002; STK629186; UNII-2I4BC502BT; SALMATEROL; Salmeterol (USAN/INN); GR 33343X; Salmeterol; 89365-50-4; SAM001247096; Salmeterolum [Latin]; NCGC00025247-02; LS-29869; DB00938; S 2692; 2-(hydroxymethyl)-4-[1-hydroxy-2-({6-[(4-phenylbutyl)oxy]hexyl}amino)ethyl]phenol; AC1L1JPX; D05792; Lopac0_001100; L000532; HMS2090E17; HMS2052H13; 2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol; BSPBio_000910; CHEMBL1263; ( inverted question mark) 4-Hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]m-ethyl]-1,3-benzenedimethanol; GR 33343X; (+-)-4-Hydroxy-alpha1-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-1,3-benzenedimethanol; 2-(hydroxymethyl)-4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)phenol; Salmeterol [USAN:BAN:INN]; (+-)-4-Hydroxy-alpha'-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-m-xylene-alpha,alpha'-diol; GR-33343X; Aeromax; MolPort-005-933-084; CID5152; C057823; Astmerole; 1,3-Benzenedimethanol, 4-hydroxy-alpha1-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-, (+-)-
Trade NameSerevent
CompanyGlaxoSmithKline
IndicationChronic obstructive pulmonary disease
[ICD9: 490-492, 494-496   ICD10: J40-J44, J47]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C25H37NO4/c27-20-23-18-22(13-14-24(23)28)25(29)19-26-15-7-1-2-
8-16-30-17-9-6-12-21-10-4-3-5-11-21/h3-5,10-11,13-14,18,25-29H,1-
2,6-9,12,15-17,19-20H2
InChIKeyGIIZNNXWQWCKIB-UHFFFAOYSA-N
Canonical SMILESC1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O    
Therapeutic ClassBronchodilator Agents
CAS NumberCAS 89365-50-4
FormulaC25H37NO4
PubChem Compound IDCID 5152.
PubChem Substance IDSID 9450.
SuperDrug ATC IDR03AC12
SuperDrug CAS ID089365504;
TargetBeta2-adrenergic receptorAgonist[2]
Ref 1Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77. Epub 2007 Feb 20. To Reference
Ref 2Pharmacogenetic tests in asthma therapy. Clin Lab Med. 2008 Dec;28(4):645-65. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543